Scrip 100
The Scrip 100 (continued)
Ranking Company Pharma sales 2007 % change Pharma sales as
($ million) % of total sales
51 Mylan 1,587 28.0 100.0
52 Covidien 1,330 9.1 13.1
53 Celgene 1,300 60.2 100.0
54 Ipsen 1,262 16.6 100.0
55 Ono Pharmaceutical 1,240 1.8 100.0
56 Dr Reddy’s Laboratories 1,193 –16.1 100.0
57 Sepracor 1,177 2.4 100.0
58 Kyowa Hakko 1,176 4.0 35.3
59 Meda 1,124 81.1 100.0
60 Almirall 1,086 14.1 100.0
61 Endo Pharmaceuticals 1,086 19.3 100.0
62 Actelion 1,078 46.1 100.0
63 Grünenthal 1,050 N/A 90.6
64 Esteve 1,049 16.4 100.0
65 Hisamitsu 1,012 7.2 100.0
66 Galderma 1,007 16.7 100.0
67 Krka 993 28.2 92.8
68 Teijin Pharma 972 –0.1 11.0
69 Cipla 972 27.7 100.0
70 Leo Pharma 965 10.7 100.0
71 Meiji Seika 963 2.1 28.0
72 Asahi Kasei Pharma 945 5.2 6.6
73 Gedeon Richter 934 14.9 100.0
74 Taiho Pharmaceutical 933 5.2 82.5
75 Sigma-Tau 912 8.2 100.0
76 Chiesi 899 20.7 100.0
77 Warner Chilcott 888 18.1 100.0
78 Santen Pharmaceutical 857 2.5 97.5
79 Recordati 851 18.9 100.0
80 Zentiva 826 32.8 100.0
81 Valeant Pharmaceuticals 818 –1.0 100.0
82 Sun Pharmaceutical Industries 813 72.0 100.0
83 Biovail 801 –21.6 100.0
84 Orion Pharma 790 16.9 84.3
85 Pierre Fabre 750 N/A N/A
86 Par Pharmaceutical 739 4.8 100.0
87 Ajinomoto 715 –0.3 7.3
88 Amylin Pharmaceuticals 701 48.0 100.0
89 Kyorin 689 3.9 100.0
90 Dong-A Pharmaceutical 687 13.4 100.0
91 Kaken Pharmaceutical 679 3.4 100.0
92 Nicholas Piramal India 667 25.4 95.9
93 Lupin 656 47.1 100.0
94 Wockhardt 643 67.9 100.0
95 Egis Pharmaceuticals 641 21.3 100.0
96 Mochida Pharmaceutical 634 –0.5 100.0
97 Kirin Holdings 594 2.8 3.9
98 KV Pharmaceutical 583 37.3 96.8
99 Toray Industries 576 –3.9 4.1
100 Cadila Healthcare 549 38.9 100.0
Source: Scrip League Tables 2008. Sales figures refer to sales by the named company itself and do not include sales by licensees or other third parties.
www.scripnews.com/supplements Scrip 100
11
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128